Kumar Shashwat

Occurrence and spectrum of cutaneous adverse drug reactions to anti-tubercular drugs among patients of drug-sensitive and drug-resistant tuberculosis-changing trends at a tertiary care center in central India

Background: Tuberculosis (TB) continues to pose a significant public health burden, particularly in resource-limited settings. Anti-tubercular therapy (ATT), though effective, is frequently associated with cutaneous adverse drug reactions (CADRs), which can lead to treatment disc...